Marshall Wace, LLP Simulations Plus, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 24,871 shares of SLP stock, worth $801,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,871
Previous 102,077
75.64%
Holding current value
$801,592
Previous $2.85 Million
78.6%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SLP
# of Institutions
172Shares Held
16.8MCall Options Held
2.6KPut Options Held
300-
Conestoga Capital Advisors, LLC2.61MShares$84.1 Million0.97% of portfolio
-
Black Rock Inc. New York, NY2.46MShares$79.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$35.4 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X0896KShares$28.9 Million0.01% of portfolio
-
State Street Corp Boston, MA707KShares$22.8 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $654M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...